Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search

We found 1,279 results for "Medical Malpractice Law & Strategy"...

Experimental Drugs and the Compassionate Use Doctrine
While gaining access to drugs not yet approved by the FDA can be a difficult task, many people will go to nearly any lengths to get them, even suing a drug manufacturer to force it to provide them the drug. That's what happened in the case of <i>Gunvalson v. PTC Therapeutics Inc.</i>, a case recently overturned on appeal.
Spoliation in a Medical Malpractice Case
Spoliation in the context of a medical malpractice case can raise many issues for lawyers representing doctors and hospitals. These issues can often be overlooked until it is too late to repair the damage done.
<b>BREAKING NEWS:</b> Eli Lilly to Pay $1.42 Billion to Settle Zyprexa Marketing Suits
Eli Lilly &amp; Co. will pay a combined $1.42 billion, including the largest criminal fine in history ' $515 million ' to settle charges that it illegally marketed the anti-psychotic drug Zyprexa for off-label use, federal prosecutors announced on Jan. 15.
Changing Internet Pharmacy Legal Standards
Telemedicine, on the scene medically and legally for several decades, is an area ' in the form, strictly speaking, of providing some kind of health care or health-care products or services ' under the Big Top of the Internet fair that is subjected regularly to regulatory scrutiny, debate, enforcement actions, improvements and all the other aspects of e-commerce, although sometimes at a slower pace than within the sector's other channels.
Decisions of Interest
Recent rulings of importance to you and your practice.
NJ & CT News
Important news from neighboring states.
Movers & Shakers
Who's doing what; who's going where.
Verdicts
Recent rulngs of importance to you and your practice.
Drug & Device News
Recent happenings in the pharmaceutical arena.
Med Mal News
The latest happenings that you need to know.

MOST POPULAR STORIES